Keros Therapeutics (KROS)
(Delayed Data from NSDQ)
$45.06 USD
-0.31 (-0.68%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $44.93 -0.13 (-0.29%) 7:44 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-1.26 | -1.22% |
Earnings Summary
For their last quarter, Keros Therapeutics (KROS) reported earnings of -$1.25 per share, missing the Zacks Consensus Estimate of -$1.23 per share. This reflects a negative earnings surprise of 1.63%. Look out for KROS's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$1.26 per share, reflecting a year-over-year increase of 5.26%.
Earnings History
Price & Consensus
Zacks News for KROS
Does Keros Therapeutics, Inc. (KROS) Have the Potential to Rally 35.66% as Wall Street Analysts Expect?
KROS: What are Zacks experts saying now?
Zacks Private Portfolio Services